secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2023-10-12T23:59:59+00:00
Accession:  0001104659-23-108864
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie expands board to 13, appoints Jennifer Davis and Susan Quaggin as directors
--------------------------------------------------------------------------------

- Board expanded from 11 to 13 directors; Jennifer Davis (Class II) and Susan Quaggin (Class III) appointed.
- Davis is CEO, Health Care at Procter & Gamble; Quaggin is Irving S. Cutter Professor and Chair of Medicine at Northwestern.
- Davis appointed to Nominations and Governance Committee; Quaggin to Public Policy and Sustainability Committee.
- Board affirmatively determined both are independent under NYSE standards and AbbVie guidelines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/0001104659-23-108864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-108864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer